Evidence map›Paper›PMID 39772364›Full record

Observational studyJournal of the American College of Cardiology2025

Myocardial Fibroblast Activation After Acute Myocardial Infarction: A Positron Emission Tomography and Magnetic Resonance Study.

Anna K Barton, Neil J Craig, Krithika Loganath, Shruti Joshi, Vasiliki Tsampasian, Menaka Mahendran, Joel Lenell, Evangelos Tzolos, Trisha Singh, Beth Whittington and 18 more

2 registry-linked trialsAbstract readObservational Study
In one paragraph

Observational study in Journal of the American College of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05356923 completednot on this map

PROline and FapI With Late Gadolinium Enhancement in Myocardial Infarction PROFILE-MI - The FAPI Fibrosis Study

TypeobservationalSponsorUniversity of EdinburghRan2021 to 2023Enrolled80ConditionsMyocardial Infarction, Myocardial FibrosisArms68Gallium FAPI PET/MR scan
NCT07657650 recruitingnot on this mapstarted 2026, after this paper: background citation

FAPl Imaging Assessment of Revascularization Outcome in Ischemic Heart Failure

TypeobservationalSponsorBeijing Chao Yang HospitalRan2026 to 2028Enrolled122ConditionsIschemic Heart FailureArmsPCI (ercutaneous coronary intervention) and CABG (coronary artery bypass grafting, commonly known as heart bypass surgery)
3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Review
  3. Coronary artery disease imaging with total-body PET.The British journal of radiology · 2026
    Review
  4. Article
  5. Observational
  6. Next-generation molecular imaging of cardiac fibrosis.The international journal of cardiovascular imaging · 2026
    Review
  7. Review
  8. Molecular Imaging of Collagen Turnover in Myocardial Infarction.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. The molecular symphony of myocardial repair: RGD, FAPI, and granzyme B PET in concert.European journal of nuclear medicine and molecular imaging · 2026
    Article
  14. Review
  15. Article
  16. NF-Frontiers in cardiovascular medicine · 2026
    Review
  17. Article
  18. Molecular contrast agents for post-infarct cardiac remodelling: a contemporary review.European heart journal. Imaging methods and practice · 2026
    Review
  19. Article
  20. [European journal of nuclear medicine and molecular imaging · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Anna K BartonBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom. Electronic address: abarton3@ed.ac.uk.
Neil J CraigBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Krithika LoganathBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Shruti JoshiBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Vasiliki TsampasianNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Menaka MahendranBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Joel LenellUppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Evangelos TzolosBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Trisha SinghBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom; Department of Cardiology, Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom.
Beth WhittingtonBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Jennifer NashBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Michelle C WilliamsBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Edwin J R van BeekEdinburgh Imaging Facility, Queen's Medical Research Institute, Edinburgh, Scotland, United Kingdom.
Mark G MacAskillBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Bronwyn BerkeleyBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Stefan VezaidesBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Mairi BrittanBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Andrew H BakerBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Stephanie SellersDepartment of Radiology and Centre for Heart Lung Innovation, St Paul's Hospital and University of British Columbia, Vancouver, British Columbia, Canada.
Alison FletcherEdinburgh Imaging Facility, Queen's Medical Research Institute, Edinburgh, Scotland, United Kingdom.
Tim ClarkEdinburgh Imaging Facility, Queen's Medical Research Institute, Edinburgh, Scotland, United Kingdom.
Clint WaightNHS Lothian, The Royal Infirmary of Edinburgh, Edinburgh, Scotland, United Kingdom.
Riemer H J A SlartMedical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, the Netherlands.
Daniel BermanDepartments of Medicine, Biomedical Sciences and Imaging, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Damini DeyDepartments of Medicine, Biomedical Sciences and Imaging, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Piotr SlomkaDepartments of Medicine, Biomedical Sciences and Imaging, Cedars-Sinai Medical Center, Los Angeles, California, USA.
David E NewbyBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Marc R DweckBritish Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.

Funding

Patient-specific Outcome Prediction from Cardiovascular Multimodality Imaging by Artificial IntelligenceR35HL161195 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI Piotr J Slomka · 2022 to 2026
$5.0M
British Heart Foundation CH/09/002/26360British Heart Foundation CH/11/2/28733NHLBI NIH HHS R35 HL161195
6 · The paper itself

Abstract

backgroundMyocardial fibrosis is a key healing response after myocardial infarction driven by activated fibroblasts. Gallium-68-labeled fibroblast activation protein inhibitor ([

objectivesThe aim of this study was to investigate the intensity, distribution, and time-course of fibroblast activation after acute myocardial infarction.

methodsA total of 40 patients with acute myocardial infarction underwent hybrid [

resultsMyocardial [

conclusionsMyocardial fibroblast activation peaks within a week of acute myocardial infarction and extends beyond the infarct region. It declines slowly with time, persists for years, and is associated with subsequent left ventricular remodeling. (PROFILE-MI-The FAPI Fibrosis Study; NCT05356923).

Indexed as

FibroblastsMagnetic Resonance ImagingMyocardial InfarctionMyocardiumPositron-Emission TomographyAgedFemaleFibrosisGallium RadioisotopesHumansMagnetic Resonance Imaging, CineMaleMiddle AgedGallium Radioisotopesfibroblast activation protein inhibitormolecular PETmyocardial Infarction

Identifiers

PMID39772364
PMCPMC11835506

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.